Exhibit 99.1
RiceBran Technologies Reports Second Quarter 2023 Results
Board continues to advance strategic review following sale of SRB business
TOMBALL, Texas, August 21, 2023 – RiceBran Technologies (NASDAQ: RIBT) (“RiceBran” or the “Company”), an innovator in the development and manufacture of nutritional and functional ingredients derived from rice, barley and oats, today announced financial results for the second quarter ended June 30, 2023.
Eric Tompkins, Executive Chairman of RiceBran, commented, “The divestiture of our stabilized rice bran (“SRB”) business during the second quarter was the first step in a process aimed to reduce costs and curb losses, creating more optionality to explore strategic alternatives and better position the Company to realize the value of its remaining assets.”
“Operationally, RiceBran delivered positive gross profit in 2Q23 from continuing operations, reversing prior quarters of gross losses, due to improved efficiency, recent capacity enhancements and higher volumes,” Tompkins added. “Moving forward we are focused on further rationalizing our costs while exploring any and all alternatives to create value. With an ongoing strategic process in place and the Company’s Board of Directors (the “Board”) actively evaluating a variety of potential outcomes, we have opted to forgo a quarterly conference call until a time when we are in a better position to share more meaningful disclosures on our strategic progress.”
Second Quarter 2023 Financial and Operational Overview
|
● |
Revenue: Total revenue from continuing operations was $6.3 million in 2Q23, down 4.7% from 2Q22 as lower MGI Grain Inc, (“MGI”) milling revenues were offset by an increase in Golden Ridge Rice Mills (“Golden Ridge”) milling revenues. |
|
● |
Gross Profit: Gross profit from continuing operations for 2Q23 was $24,000 compared to a gross loss of $0.4 million in the second quarter of 2022, reflecting higher gross profit at Golden Ridge related to increased volume and at MGI due to the elimination of certain operational inefficiencies. |
|
● |
SG&A and Operating Loss: SG&A from continuing operations increased $0.4 million year-over-year due to increased legal costs as the Board continues to explore strategic alternatives. Loss from continuing operations before other income (expense) was $1.6 million in 2Q23, consistent with 2Q22, because the impact of improved gross margins was offset by increased legal expenses. |
|
● |
Loss from Continuing Operations and Loss from Discontinued Operations: The Company reported a loss from continuing operations of $1.8 million in 2Q23 compared to $2.2 million in 2Q22. RiceBran also reported a loss from discontinued operations of $8.5 million in 2Q23 compared to $447,000 in 2Q22. The loss from discontinued operations reflects the sale of the SRB business, including a loss on the sale of $8.6 million. |
|
● |
Net Loss and EPS: Inclusive of the loss from discontinued operations, net loss was $10.3 million in 2Q23 compared to $2.6 million in 2Q22. Loss per share from continuing operations was $(0.27) in 2Q23 compared to $(0.41) in 2Q22. Loss per share from discontinued operations was $(1.27) in 2Q23 compared to $(0.09) in 2Q22. |
Balance Sheet: Total cash was $0.3 million at the end of 2Q23 down from $3.9 million at the end of 4Q22, after repayments of $3.0 million on the Company’s factoring, line of credit and long-term debt and finance lease liabilities. Our current liquidity, consisting of cash and availability from our factoring facility, is $0.6 million.
In our continuing operations, during the first half of 2023, we used $1.3 million of cash to fund operating activities and $0.3 million for capital expenditures. This was offset by the $1.0 million of cash provided by the SRB business’ operations and its June 23,2023 disposition.
About RiceBran Technologies
RiceBran Technologies is a specialty ingredient company focused on the development, production and marketing of products derived from traditional and ancient small grains. We create and produce products to deliver improved nutrition and ease of use, while addressing consumer demand for all natural, non-GMO and organic products. The target markets for our products include human food, animal nutrition manufacturers and retailers, as well as specialty food retailers. More information can be found in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and by visiting our website at http://www.ricebrantech.com.
Forward-Looking Statements
This press release includes statements concerning RiceBran and its future expectations, plans and prospects that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such “forward-looking statements” include, but are not limited to, statements about RiceBran’s intentions, beliefs or current expectations. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “would,” “expect,” “plans,” “anticipate,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these terms or other similar expressions. The forward-looking statements in this press release are based on current expectations, estimates, forecasts and projections about the industry and markets in which the Company operates and management’s beliefs and assumptions. The Company cannot guarantee that it actually will achieve the plans, intentions, expectations or guidance disclosed herein. Such forward-looking statements, and all phases of the Company’s operations, involve a number of risks and uncertainties, any one or more of which could cause actual results to differ materially from those described in its forward-looking statements. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran’s filings with the SEC, including its most recent annual report on Form 10-K and its quarterly reports on Forms 10-Q. Except as required by law, RiceBran does not undertake to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information.
Investor Contact
Rob Fink
FNK IR
ribt@fnkir.com
646.809.4048
RiceBran Technologies
Condensed Consolidated Statements of Operations
(Unaudited) (in thousands, except share and per share amounts)
|
3 Months Ended |
6 Months Ended |
|||||||||||||||||||||||
|
6/30/23 |
6/30/22 |
% Chg. |
6/30/23 |
6/30/22 |
% Chg. |
|||||||||||||||||||
|
Revenue |
$ | 6,269 | $ | 6,581 | (5 | %) | $ | 12,113 | $ | 12,572 | (4 | %) | ||||||||||||
|
Cost of Goods Sold |
(6,245 | ) | (6,970 | ) | (10 | %) | (12,147 | ) | $ | (12,993 | ) | (7 | %) | |||||||||||
|
Gross Profit (Loss) |
24 | (389 | ) | NM | (34 | ) | (421 | ) | (92 | %) | ||||||||||||||
|
Gross Margin |
0 | % | (6 | %) | (0 | %) | (3 | %) | ||||||||||||||||
|
Selling, General & Admin. |
(1,644 | ) | (1,215 | ) | 35 | % | (3,102 | ) | (2,585 | ) | 20 | % | ||||||||||||
|
Loss from continuing ops before other income (expense) |
$ | (1,620 | ) | $ | (1,604 | ) | 1 | % | $ | (3,136 | ) | $ | (3,006 | ) | 4 | % | ||||||||
|
Interest Expense |
(166 | ) | (104 | ) | 60 | % | (326 | ) | (216 | ) | 51 | % | ||||||||||||
|
Change in FV of Derivative Warrant Liability |
(11 | ) | (417 | ) | (97 | %) | (39 | ) | (588 | ) | (93 | %) | ||||||||||||
|
Other Income (Expense) |
(34 | ) | (37 | ) | (8 | %) | 162 | (67 | ) | NM | ||||||||||||||
|
Loss From Continuing Ops Before Income Taxes |
(1,831 | ) | (2,162 | ) | (15 | %) | (3,339 | ) | (3,877 | ) | (14 | %) | ||||||||||||
|
Income Taxes |
(5 | ) | (12 | ) | (58 | %) | (11 | ) | (12 | ) | (8 | %) | ||||||||||||
|
Loss From Continuing Ops |
(1,836 | ) | (2,174 | ) | (16 | %) | (3,350 | ) | (3,889 | ) | (14 | %) | ||||||||||||
|
Loss From Discontinued Ops |
(8,495 | ) | (447 | ) | 1800 | % | (9,009 | ) | (248 | ) | 3533 | % | ||||||||||||
|
Net Loss |
$ | (10,331 | ) | $ | (2,621 | ) | 294 | % | $ | (12,359 | ) | $ | (4,137 | ) | 199 | % | ||||||||
|
Basic & Diluted Loss per Share: |
||||||||||||||||||||||||
|
Continuing Ops |
$ | (0.27 | ) | $ | (0.41 | ) | (34 | %) | $ | (0.50 | ) | $ | (0.74 | ) | (32 | %) | ||||||||
|
Discontinued Ops |
$ | (1.27 | ) | $ | (0.09 | ) | 1311 | % | $ | (1.36 | ) | $ | (0.05 | ) | 2620 | % | ||||||||
| $ | (1.54 | ) | $ | (0.50 | ) | 208 | % | $ | (1.86 | ) | $ | (0.79 | ) | 135 | % | |||||||||
|
Weighted Avg. Shares Outstanding (Basic & Diluted): |
6,723 | 5,286 | 27 | % | 6,646 | 5,270 | 26 | % | ||||||||||||||||
RiceBran Technologies
Condensed Consolidated Balance Sheets
(Unaudited) (in thousands, except share amounts)
|
Period Ending |
||||||||||||
|
6/30/23 |
12/31/22 |
% Chg. |
||||||||||
|
Assets |
||||||||||||
|
Cash and Cash Equivalents |
$ | 302 | $ | 3,941 | (92 | %) | ||||||
|
Accounts Receivable, net |
3,368 | 3,703 | (9 | %) | ||||||||
|
Inventories |
466 | 465 | - | |||||||||
|
Other Current Assets |
667 | 735 | (9 | %) | ||||||||
|
Current assets held for sale |
- | 2,224 | NM | |||||||||
|
Total Current Assets |
$ | 4,803 | $ | 11,068 | (57 | %) | ||||||
|
PP&E, Net |
6,213 | 6,020 | 3 | % | ||||||||
|
Operating Lease right-of-use assets |
26 | 77 | (66 | %) | ||||||||
|
Intangibles |
323 | 380 | (15 | %) | ||||||||
|
Long-term assets held for sale |
- | 9,888 | NM | |||||||||
|
Total Assets |
$ | 11,365 | $ | 27,433 | (59 | %) | ||||||
|
Liabilities and Shareholders' Equity |
||||||||||||
|
Accounts Payable |
$ | 1,441 | $ | 1,232 | 17 | % | ||||||
|
Commodities Payable |
1,752 | 1,546 | 13 | % | ||||||||
|
Accruals |
2,348 | 1,584 | 48 | % | ||||||||
|
Leases, Current |
177 | 220 | (20 | %) | ||||||||
|
Debt, Current |
3,739 | 6,155 | (39 | %) | ||||||||
|
Current liabilities held for sale |
- | 540 | NM | |||||||||
|
Total Current Liabilities |
$ | 9,457 | $ | 11,277 | (16 | %) | ||||||
|
Leases, Not Current |
464 | 320 | 45 | % | ||||||||
|
Debt, Not Current |
454 | 836 | (46 | %) | ||||||||
|
Derivative Warrant Liability |
108 | 69 | 57 | % | ||||||||
|
Long-term liabilities held for sale |
- | 2,022 | NM | |||||||||
|
Total Liabilities |
$ | 10,483 | $ | 14,524 | (28 | %) | ||||||
|
Preferred Stock |
75 | 75 | - | |||||||||
|
Common Stock |
328,883 | 328,551 | - | |||||||||
|
Accumulated Deficit |
(328,076 | ) | (315,717 | ) | 4 | % | ||||||
|
Total Shareholders’ Equity |
$ | 882 | $ | 12,909 | (93 | %) | ||||||
|
Total Liabilities and Shareholders’ Equity |
$ | 11,365 | $ | 27,433 | (59 | %) | ||||||
|
RiceBran Technologies |
||||||||
|
Consolidated Statement of Cash Flows (Unaudited) |
||||||||
|
(Unaudited) (in thousands, except share amounts) |
||||||||
|
6 Months Ended |
||||||||
|
6/30/23 |
6/30/22 |
|||||||
|
Cash Flow from Operations |
||||||||
|
Net Loss |
$ | (12,359 | ) | $ | (4,137 | ) | ||
|
Loss from discontinued ops |
$ | (9,009 | ) | $ | (248 | ) | ||
|
Loss from continuing ops |
$ | (3,350 | ) | $ | (3,889 | ) | ||
|
Adjs. to reconcile net loss to net cash used in operating activities of continuing ops: |
||||||||
|
Depreciation |
465 | 440 | ||||||
|
Amortization |
57 | 81 | ||||||
|
Share-Based Compensation |
239 | 323 | ||||||
|
Change in FV of Derivative Warrant Liability |
39 | 588 | ||||||
|
Other |
(16 | ) | 10 | |||||
|
Changes in operating assets and liabilities: |
||||||||
|
Accounts Receivable |
337 | (20 | ) | |||||
|
Inventories |
(1 | ) | 227 | |||||
|
Accounts Payable |
611 | 454 | ||||||
|
Commodities Payable |
206 | 10 | ||||||
|
Other |
68 | (437 | ) | |||||
|
Net Cash Flow from Continuing Ops |
$ | (1,345 | ) | $ | (2,213 | ) | ||
|
Net Cash Flow from Discontinued Ops |
$ | (211 | ) | $ | 475 | |||
|
Net Cash Flow from Operating Activities |
$ | (1,556 | ) | $ | (1,738 | ) | ||
|
Cash Flow from Investing |
||||||||
|
Purchases of PP&E |
(317 | ) | (132 | ) | ||||
|
Net Cash Flow from Investing from Continuing Ops |
(317 | ) | (132 | ) | ||||
|
Net Cash Flow from Investing from Discontinued Ops |
1,679 | (180 | ) | |||||
|
Net Cash Flow from Investing Activities |
$ | 1,362 | $ | (312 | ) | |||
|
Cash Flow from Financing |
||||||||
|
Net Change in Debt |
(2,985 | ) | 1,362 | |||||
|
Net Cash Flow from Financing from Continuing Ops |
(2,985 | ) | 1,362 | |||||
|
Net Cash Flow from Financing from Discontinued Ops |
(460 | ) | (13 | ) | ||||
|
Net Cash Flow from Financing |
$ | (3,445 | ) | $ | 1,349 | |||
|
Net Change in Cash |
$ | (3,639 | ) | $ | (701 | ) | ||
|
BOP Cash Balance |
$ | 3,941 | $ | 5,825 | ||||
|
Net Change in Cash |
(3,639 | ) | (701 | ) | ||||
|
EOP Cash Balance |
$ | 302 | $ | 5,124 | ||||